为进一步探讨矮小儿童的诊治,对80例身高<2SD儿童进行了临床研究,并选择25例身高>-2SD、<(?)儿童做对照。结果显示,垂体侏儒、甲低的身高、骨龄明显落后(p<0.01),其他侏儒82%骨龄与实际年龄相符;国产重组人生长激素治疗垂体侏儒,6个月身高平均增长8.1cm。由此可见,骨龄可作为矮小儿童的初筛检查,同时还作T_4、TSH筛查;垂体侏儒的诊断需作两种激发试验;国产重组人生长激素治疗垂体侏儒效果良好。 In order to further explore the diagnosis and treatment of dwarf children, 80 children <2SD were studied clinically and 25 children> -2SD were selected as controls. The results showed that the pituitary dwarf, hypothyroidism and bone age obviously lagged behind (p <0.01). Other gnomes 82% bone age were consistent with the actual age. Domestic recombinant human growth hormone treated pituitary gnome with an average growth of 8.1 cm at 6 months. Thus, the bone age can be used as a screening test for short children, but also for T_4, TSH screening; pituitary dwarf diagnosis need to do two kinds of challenge test; domestic recombinant human growth hormone treatment of pituitary dwarf good effect.